http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#Head
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#provenance
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#pubinfo
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion
http://purl.obolibrary.org/obo/DOID_5419
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_5419
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB04946
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
http://www.w3.org/2000/01/rdf-schema#label
fanapt r see clinical studies 14 when deciding among the alternative treatments available for this condition the prescriber should consider the finding that fanapt see warnings and precaution s 5 2 patients must be titrated to an effective dose of fanapt s ee dosage and administration 2 1 and clinical studies 14 the effectiveness of fanapt in long term use that is for more than 6 weeks has not been systematically evaluated in controlled trials therefore the physician who elects to use fanapt for extended periods should periodically re evaluate the long term usefulness of the drug for the individual patient s ee dosage and administration 2 3 fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults 1 14
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB04946
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#provenance
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#pubinfo
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig
http://purl.org/nanopub/x/hasSignature
LAWb6yYRdhbvj0frGpxVWRSuBuWqf5ZYjKBNw8hs3syZydbXSyWWNzP4Il6Jt0hW2S0RxPhk56qLx89Z/0RN5tU0PeV9vjBeyhAURmPmZBbPfaGJ9mSKUsOaWzi0BwWiXOSjFfEkJY8qie/IkZ2xiigG4BVzf861nFYy4Trz+ik=
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://purl.org/dc/terms/created
2021-07-03T11:41:09.959+02:00
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RA__616KtAcNHmNYBBVhXtcYGBrRfgNSei71FcUBr3mhg
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs